The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES
KARNOVSKY, M. J., & ROOTS, L. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.219 · Cited by 3,367
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products
Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., & Nachon, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210241200 · Cited by 840
Self-citationPREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS
Sevitt, S., & Gallagher, N. G. (1959) · The Lancet · doi:10.1016/s0140-6736(59)91464-3 · Cited by 651
Polyproline-II Helix in Proteins: Structure and Function
Adzhubei, A. A., Sternberg, M. J. E., & Makarov, A. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.018 · Cited by 547
Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E. G., Masson, P., & Lockridge, O. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.002 · Cited by 540
Self-citationMackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D. H., Hill, E., Roberts, C., Durrington, P. N., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.094247 · Cited by 435
Complete amino acid sequence of human serum cholinesterase.
Lockridge, O., Bartels, C. F., Vaughan, T. A., Wong, C. K., Norton, S. E., & Johnson, L. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75818-9 · Cited by 376
Self-citationMendel, B., & Rudney, H. (1943) · Biochemical Journal · doi:10.1042/bj0370059 · Cited by 335
Kalow, W., & Staron, N. (1957) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o57-148 · Cited by 334
Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites
De Vriese, C., Gregoire, F., Lema-Kisoka, R., Waelbroeck, M., Robberecht, P., & Delporte, C. (2004) · Endocrinology · doi:10.1210/en.2004-0569 · Cited by 309
The Origin of the Molecular Diversity and Functional Anchoring of Cholinesterases
Massoulié, J. (2002) · Neurosignals · doi:10.1159/000065054 · Cited by 281
Perrier, A. L., Massoulié, J., & Krejci, E. (2002) · Neuron · doi:10.1016/s0896-6273(01)00584-0 · Cited by 248
Pharmacogenetics. Heredity and the Response to Drugs.
(1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-58-4-757 · Cited by 242
Plasma cholinesterase variants and the anaesthetist
WHITTAKER, M. (1980) · Anaesthesia · doi:10.1111/j.1365-2044.1980.tb03800.x · Cited by 236
Hydrolysis of cocaine in human plasma by cholinesterase
Stewart, D. J., Inaba, T., Tang, B. K., & Kalow, W. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90448-9 · Cited by 221
Fidder, A., Hulst, A. G., Noort, D., de Ruiter, R., van der Schans, M. J., Benschop, H. P., & Langenberg, J. P. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0101806 · Cited by 216
Huang, Y.-J., Huang, Y., Baldassarre, H., Wang, B., Lazaris, A., Leduc, M., Bilodeau, A. S., Bellemare, A., Côté, M., Herskovits, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702756104 · Cited by 214
Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity
Raveh, L., Grunwald, J., Marcus, D., Papier, Y., Cohen, E., & Ashani, Y. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90228-o · Cited by 210
Bartels, C. F., Jensen, F. S., Lockridge, O., van der Spek, A. F., Rubinstein, H. M., LUBRANO, T., & Du, B. N. L. (1992) · PubMed · Cited by 203
Self-citationMcGuire, M. C., Nogueira, C. P., Bartels, C. F., Lightstone, H., Hajra, A., Van der Spek, A. F., Lockridge, O., & La Du, B. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.953 · Cited by 185
Self-citationAnatoxin-a(s), an anticholinesterase from the cyanobacterium Anabaena flos-aquae NRC-525-17
Mahmood, N. A., & Carmichael, W. W. (1987) · Toxicon · doi:10.1016/0041-0101(87)90140-1 · Cited by 171
Progress in the development of enzyme-based nerve agent bioscavengers
Nachon, F., Brazzolotto, X., Trovaslet, M., & Masson, P. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.06.012 · Cited by 165
Lockridge, O., Blong, R. M., Masson, P., Froment, M.-T., Millard, C. B., & Broomfield, C. A. (1997) · Biochemistry · doi:10.1021/bi961412g · Cited by 162
Self-citationHartmann, J., Kiewert, C., Duysen, E. G., Lockridge, O., Greig, N. H., & Klein, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04347.x · Cited by 161
Self-citationStructure of the gene for human butyrylcholinesterase. Evidence for a single copy
Arpagaus, M., Kott, M., Vatsis, K. P., Bartels, C. F., La Du, B. N., & Lockridge, O. (1990) · Biochemistry · doi:10.1021/bi00453a015 · Cited by 159
Self-citationMuratani, K., Hada, T., Yamamoto, Y., Kaneko, T., Shigeto, Y., Ohue, T., Furuyama, J.-I., & Higashino, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11315 · Cited by 155
Duysen, E. G., Li, B., Xie, W., Schopfer, L. M., Anderson, R. S., Broomfield, C. A., & Lockridge, O. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29259-4 · Cited by 148
Self-citationPseudo-esterase Activity of Human Albumin
Lockridge, O., Xue, W., Gaydess, A., Grigoryan, H., Ding, S., Schopfer, L. M., Hinrichs, S. H., & Masson, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802555200 · Cited by 127
Self-citationBrazzolotto, X., Wandhammer, M., Ronco, C., Trovaslet, M., Jean, L., Lockridge, O., Renard, P., & Nachon, F. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08672.x · Cited by 126
Self-citationManoharan, I., Boopathy, R., Darvesh, S., & Lockridge, O. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.11.005 · Cited by 122
Self-citationCholinesterases : structure, function, mechanism, genetics, and cell biology
Massoulié, J. (1991) · HAL · Cited by 121
Increased plasma cholinesterase activity and succinylcholine resistance: a genetic variant.
Neitlich, H. W. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105353 · Cited by 116
Johnson, G., & Moore, S. W. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.016 · Cited by 103
Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.
Primo-Parmo, S. L., Bartels, C. F., Wiersema, B., van der Spek, A. F., Innis, J. W., & Du, B. N. L. (1996) · PubMed · Cited by 102
Duysen, E. G., Li, B., Darvesh, S., & Lockridge, O. (2006) · Toxicology · doi:10.1016/j.tox.2006.11.069 · Cited by 102
Self-citationLamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers
Li, H., Schopfer, L. M., Masson, P., & Lockridge, O. (2008) · Biochemical Journal · doi:10.1042/bj20071551 · Cited by 95
Self-citationLockridge, O., Schopfer, L. M., Winger, G. D., et al. (2005) · PubMed · doi:10.1901/jaba.2005.3-nihms5095 · Cited by 91
Self-citationCLINICAL EXPERIENCE WITH CHLOROTHIAZIDE
Slater, J. D., & Nabarro, J. D. N. (1958) · The Lancet · doi:10.1016/s0140-6736(58)90611-1 · Cited by 90
Chemical nature of the DFP-binding site of pseudocholinesterase
Jansz, H. S., Brons, D., & Warringa, M. G. P. J. (1959) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(59)90320-8 · Cited by 89
Tissue distribution of human acetylcholinesterase and butyrylcholinesterase messenger RNA
Jbilo, O., Bartels, C. F., Chatonnet, A., et al. (1994) · Toxicon · doi:10.1016/0041-0101(94)90416-2 · Cited by 87
Therapeutic Use of Butyrylcholinesterase for Cocaine Intoxication
Mattes, C. E., Lynch, T. J., Singh, A., Bradley, R. M., Kellaris, P. A., Brady, R. O., & Dretchen, K. L. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8188 · Cited by 85
Brimijoin, S., & HAMMOND, P. I. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb03091.x · Cited by 85
Simon, S., Krejci, É., & Massoulié, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6178 · Cited by 83
Isolierung und physikalisch-chemische Charakterisierung der Cholinesterase aus Humanserum
HAUPT, H., Heide, K., Zwisler, O., et al. (1966) · Annals of Hematology · doi:10.1007/bf01633493 · Cited by 80
Grunwald, J., Marcus, D., Papier, Y., Raveh, L., Pittel, Z., & Ashani, Y. (1997) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(97)01208-6 · Cited by 79
DNA mutations associated with the human butyrylcholinesterase J-variant.
Bartels, C. F., James, K., & Du, B. N. L. (1992) · PubMed · Cited by 77
Butyrylcholinesterase as a biochemical marker
Pohanka, M. (2013) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2013_153 · Cited by 77
Nogueira, C. P., McGuire, M. C., Graeser, C., Bartels, C. F., Arpagaus, M., van der Spek, A. F., Lightstone, H., Lockridge, O., & Du, B. N. L. (1990) · PubMed · Cited by 69
Self-citationTransgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase
Geyer, B. C., Kannan, L., Cherni, I., Woods, R. R., Soreq, H., & Mor, T. S. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2010.00515.x · Cited by 66
Reversible Phosphorylation of Histidine Residues in Proteins from Vertebrates
Klumpp, S., & Krieglstein, J. (2009) · Science Signaling · doi:10.1126/scisignal.261pe13 · Cited by 64
Huang, Y., Lundy, P. M., Lazaris, A., Huang, Y., Baldassarre, H., Wang, B., Turcotte, C., Côté, M., Bellemare, A., Bilodeau, A. S., et al. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-50 · Cited by 60
Cyclophostin, acetylocholinesterase inhibitor from Streptomyces lavendulae.
KUROKAWA, T., Suzuki, K., Hayaoka, T., Nakagawa, T., IZAWA, T., Kobayashi, M., & HARADA, N. (1993) · The Journal of Antibiotics · doi:10.7164/antibiotics.46.1315 · Cited by 59
Worek, F., Seeger, T., Goldsmith, M., Ashani, Y., Leader, H., Sussman, J. L., Tawfik, D. S., Thiermann, H., & Wille, T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1204-z · Cited by 59
Insecticidal organophosphates: Nature made them first
Neumann, R., & Peter, H. H. (1987) · Cellular and Molecular Life Sciences · doi:10.1007/bf01945541 · Cited by 58
Experimental Treatments for Cocaine Toxicity: A Difficult Transition to the Bedside
Connors, N. J., & Hoffman, R. S. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206383 · Cited by 57
Manoharan, I., Wieseler, S., Layer, P. G., Lockridge, O., & Boopathy, R. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000197464.37211.77 · Cited by 52
Self-citationEvidence for Non-Allelism between Genes Affecting Human Serum Cholinesterase
Harris, H., ROBSON, E. B., Glen-Bott, A. M., et al. (1963) · Nature · doi:10.1038/2001185a0 · Cited by 52
Nogueira, C. P., Bartels, C. F., McGuire, M. C., Adkins, S., LUBRANO, T., Rubinstein, H. M., Lightstone, H., Spek, A. F. L. V. D., Lockridge, O., & Du, B. N. L. (1992) · PubMed · Cited by 49
Self-citationModel of Human Butyrylcholinesterase Tetramer by Homology Modeling and Dynamics Simulation
Pan, Y., Muzyka, J. L., & Zhan, C. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8114995 · Cited by 48
Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan
Maekawa, M., Sudo, K., Dey, D. C., Ishikawa, J., Izumi, M., Kotani, K., & Kanno, T. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.6.924 · Cited by 48
Gätke, M. R., Bundgaard, J. R., & Viby-Mogensen, J. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f06646 · Cited by 46
Rosenberg, Y. J., Saxena, A., Sun, W., Jiang, X., Chilukuri, N., Luo, C., Doctor, B. P., & Lee, K. D. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.02.042 · Cited by 45
Parikh, K., Duysen, E. G., Snow, B., Jensen, N. S., Manne, V., Lockridge, O., & Chilukuri, N. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175646 · Cited by 44
Self-citationDelacour, H., Lushchekina, S. V., Mabboux, I., Bousquet, A., Ceppa, F., Schopfer, L. M., Lockridge, O., & Masson, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101552 · Cited by 44
Self-citationGaydess, A., Duysen, E. G., Yuan, L., Gilman, V., Kabanov, A. V., Lockridge, O., & Bronich, T. K. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.005 · Cited by 44
Self-citationGnatt, A. L., Prody, C. A., Zamir, R., Lieman‐Hurwitz, J., Zakut, H. V., & Soreq, H. (1990) · PubMed · Cited by 44
Geng, L., Gao, Y., Chen, X., Hou, S., Zhan, C., Radić, Z., Parks, R. J., Russell, S. J., Pham, L., & Brimijoin, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067446 · Cited by 42
Anker, J. J., Brimijoin, S., Gao, Y., Geng, L., Zlebnik, N. E., Parks, R. J., & Carroll, M. E. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.014 · Cited by 37
The proline‐rich tetramerization peptides in equine serum butyrylcholinesterase
Biberoğlu, K., Schopfer, L. M., Tacal, Ö., & Lockridge, O. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08744.x · Cited by 34
Self-citationWeber, A., Butterweck, H. A., Mais‐Paul, U., Teschner, W., Lei, L. S., Muchitsch, E. M., Kolarich, D., Altmann, F., Ehrlich, H. J., & Schwarz, H. P. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2010.01415.x · Cited by 33
Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes
Maekawa, M., Sudo, K., Kanno, T., Kotani, K., Dey, D. C., Ishikawa, J., Izumi, M., & Etoh, K. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06014-1 · Cited by 32
Physiologic and metabolic safety of butyrylcholinesterase gene therapy in mice
Murthy, V., Gao, Y., Geng, L., LeBrasseur, N. K., White, T. A., Parks, R. J., & Brimijoin, S. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.067 · Cited by 29
Masson, P., Chatonnet, A., & Lockridge, O. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80167-h · Cited by 28
Self-citationDelacour, H., Lushchekina, S. V., Mabboux, I., Ceppa, F., Masson, P., Schopfer, L. M., & Lockridge, O. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.09.014 · Cited by 27
Self-citationBoudinot, É., Taysse, L., Daulon, S., Chatonnet, A., Champagnat, J., & Foutz, A. S. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.014 · Cited by 23
Checler, F., Grassi, J. J., Masson, P., & Vincent, J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04555.x · Cited by 21
Liu, X., Hou, S., Yang, W., Fang, L., Zheng, F., & Zhan, C. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.08.003 · Cited by 19
Barricklow, J., & Blatnik, M. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.05.003 · Cited by 18
Cocaine Hydrolase Gene Therapy for Cocaine Abuse
Brimijoin, S., & Gao, Y. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.183 · Cited by 18
Butyrylcholinesterase: Overview, Structure, and Function
Lockridge, O., Duysen, E. G., & Masson, P. (2011) · doi:10.1002/9780470640500.ch3 · Cited by 17
Self-citationAkizuki, S., Ohnishi, A., Kotani, K., & Sudo, K. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.201 · Cited by 17
Polyproline tetramer organizing peptides in fetal bovine serum acetylcholinesterase
Biberoğlu, K., Schopfer, L. M., Saxena, A., Tacal, Ö., & Lockridge, O. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.01.009 · Cited by 15
Self-citationTwo new mutations of the human BCHE gene (IVS3-14T>C and L574fsX576)
Parmo-Folloni, F., Nunes, K., Lepienski, L. M., Mikami, L. R., de Souza, R. L. R., Tsuneto, L. T., Petzl‐Erler, M. L., & Chautard‐Freire‐Maia, E. A. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.038 · Cited by 9
Newly Observed Spontaneous Activation of Ethephon as a Butyrylcholinesterase Inhibitor
Liyasova, M., Schopfer, L. M., Kodani, S. D., Lantz, S. R., Casida, J. E., & Lockridge, O. (2013) · Chemical Research in Toxicology · doi:10.1021/tx300501n · Cited by 8
Self-citation
Cited by
Li, Q., Yang, H., Chen, Y., & Sun, H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.062 · Cited by 322
Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
Nalivaeva, N. N., Turner, A. J., & Zhuravin, I. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00825 · Cited by 181
Hoffmann, M., Stiller, C., Endres, E., Scheiner, M., Gunesch, S., Sotriffer, C., Maurice, T., & Decker, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01012 · Cited by 105
Therapeutic Delivery of Butyrylcholinesterase by Brain-Wide Viral Gene Transfer to Mice
Gao, Y., Geng, L., Chen, V., & Brimijoin, S. (2017) · Molecules · doi:10.3390/molecules22071145 · Cited by 12
Prešern, U., Goličnik, M., & Bavec, A. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111809 · Cited by 13
Metadata
- Authors
- Lockridge, O.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 148
- Pages
- 34-46
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2047441116
- Cited by
- 420
- References
- 84
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.